Seminario web bajo demanda
¿Cómo es la radioterapia moderna para el cáncer de mama?
27 mayo 2021
· 20 MIN VER
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.100.100.4,0,465,461.file/pedro-lara.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.360.360.4,0,465,461.file/pedro-lara.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.461.461.4,0,465,461.file/pedro-lara.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.461.461.4,0,465,461.file/pedro-lara.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.461.461.4,0,465,461.file/pedro-lara.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.461.461.4,0,465,461.file/pedro-lara.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/pedro-lara.jpg/_jcr_content/renditions/original.image_file.461.461.4,0,465,461.file/pedro-lara.jpg"})
Autor
Prof. Dr. Pedro Lara, doctorado
Profesor y jefe de radiología, Universidad Fernando Pessoa de Canarias, jefe del Departamento de Oncología en el Hospital Universitario de San Roque, Gran Canaria, España
Resumen
El Prof. Pedro Lara habla sobre cómo es el tratamiento moderno de radiación para el cáncer de mama y cuál es el papel especial de APBI en este entorno de tratamiento
Este seminario web clínico grabado empieza con un breve resumen sobre los aspectos clave de la radioterapia de toda la mama (WBRT) y de la importante función de la irradiación parcial acelerada de mama (APBI). Después, el Prof. Pedro Lara se centra concretamente en la radioterapia intraoperatoria (RIO), incluyendo un repaso rápido de los resultados a largo plazo de TARGIT-A recién publicados y explica por qué la RIO es un buen enfoque para tratar el lecho de la herida donde están ubicados los posibles márgenes del tumor.
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.100.56.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.360.203.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.768.432.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.1024.576.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.1280.720.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.1440.810.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/626-how-does-modern-breast-cancer-radiation-treatment-look-like-/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg/_jcr_content/renditions/original.image_file.1869.1051.23,12,1892,1064.file/626-how-does-modern-breast-cancer-radiation-treatment-look-like-_preview.jpg"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.100.56.79,35,1331,739.file/627-sperk-targit-a-preview.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.360.203.79,35,1331,739.file/627-sperk-targit-a-preview.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.768.432.79,35,1331,739.file/627-sperk-targit-a-preview.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1024.576.79,35,1331,739.file/627-sperk-targit-a-preview.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1252.704.79,35,1331,739.file/627-sperk-targit-a-preview.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1252.704.79,35,1331,739.file/627-sperk-targit-a-preview.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/627-targit-a-_-comparison-to-other-apbi-studies/627-sperk-targit-a-preview.png/_jcr_content/renditions/original.image_file.1252.704.79,35,1331,739.file/627-sperk-targit-a-preview.png"})
![]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original.image_file.100.56.file/preview.png","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original.image_file.360.203.file/preview.png","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/myzeiss/peer-insights/free/iort/628-how-can-targit-a-have-positive-effects-on-reimbursement-guidelines-/preview.png/_jcr_content/renditions/original./preview.png"})